LIVN.NASDAQLivanova PLC

SCHEDULE: PRIMECAP Maintains 7.74% Stake in LivaNova PLC

Sentiment:

Beneficial Ownership Disclosure


PRIMECAP Management Co./CA/ has filed an Amendment No. 8 to Schedule 13G, disclosing a 7.74% beneficial ownership in LivaNova PLC as of December 31, 2025.

Summary

  • PRIMECAP Management Co./CA/ beneficially owns 4,224,852 shares of LivaNova PLC's common stock.
  • This ownership represents 7.74% of LivaNova PLC's outstanding class of securities.
  • PRIMECAP holds sole voting power over 4,203,362 shares.
  • PRIMECAP holds sole dispositive power over 4,224,852 shares.
  • The filing is an Amendment No. 8, indicating a long-standing investment position by PRIMECAP.
  • PRIMECAP Management Co./CA/ is classified as an Investment Adviser (IA).
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of LivaNova PLC.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, as it confirms a significant, passive institutional stake, which can be a sign of stability and long-term investor confidence in LivaNova PLC.

Positives

  • The continued significant stake by PRIMECAP Management Co./CA/, a reputable investment adviser, suggests ongoing institutional confidence in LivaNova PLC.
  • The filing indicates a passive, long-term investment strategy, which can contribute to share price stability.

Negatives

  • The filing itself does not contain any negative information regarding LivaNova PLC's operations or financial performance.

Risks

  • The filing does not detail specific risks related to LivaNova PLC's business or operations.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing, particularly an amendment from a long-term institutional investor like PRIMECAP Management Co./CA/, typically signals continued confidence in the issuer's long-term prospects. Such filings are common for large asset managers and do not usually indicate a change in investment strategy or a new activist position, but rather a routine update of their passive stake.

Stakeholder Impact

  • Shareholders may view the continued significant ownership by a major institutional investor as a positive indicator of stability and long-term value, potentially bolstering investor confidence.

Key Dates

DateDescription
12/31/2025Date of event which requires filing of this statement (reporting period end).
02/12/2026Date of signature for the Schedule 13G/A filing.

Recommendation

hold

The filing is a routine disclosure of a passive, long-term institutional ownership stake. It does not contain new information that would fundamentally alter the investment thesis for LivaNova PLC, nor does it suggest any immediate catalysts for significant price movement. Therefore, a 'hold' recommendation is appropriate for investors who already have a position, reflecting the stability implied by a consistent institutional holder.

Keywords

LivaNova PLC, PRIMECAP MANAGEMENT CO/CA/, Schedule 13G, Beneficial Ownership, Institutional Investor, Medical Devices, Healthcare, Investment Adviser

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.